FDA Approves LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Macleods Pharmaceuticals Limited

# FDA Approves Generic Losartan Potassium and Hydrochlorothiazide Combination Macleods Pharmaceuticals Limited received FDA approval for its generic losartan potassium and hydrochlorothiazide combination therapy, expanding affordable treatment options in the competitive antihypertensive market. The approval is expected to increase price competition and improve patient access to this widely-prescribed dual-action blood pressure medication.